Prakt. lékáren. 2021; 17(1): e03-e13 | DOI: 10.36290/lek.2021.014

Erectile dysfunction and possibilities of its therapy from the perspective of a pharmacist

Ondřej Šimandl1, 2
1 EUC Lékárna, Poliklinika Malešice, Praha
2 Ústav farmakologie, 2. lékařská fakulta Univerzity Karlovy, Praha

Erectile dysfunction affects more than half of men over the age of 50 worldwide. Its causes can be various - somatic and psychological. Effective treatment of erectile dysfunction, incl. elimination of the causative cause, leads to improved couple satisfaction and improved quality of life of man and his health. The pharmacist also plays an important role in the prevention and treatment of this disease.

Keywords: erectile dysfunction, therapy, pharmaceutical care.

Published: April 15, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šimandl O. Erectile dysfunction and possibilities of its therapy from the perspective of a pharmacist. Praktické lékárenství. 2021;17(1):e03-13. doi: 10.36290/lek.2021.014.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kratochvíl S. Sexuální dysfunkce. 3., dopl. a aktualiz. vyd. Praha: Grada, 2008. Psyché (Grada). ISBN 978-80-247-2476-8.
    2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol. 1994; 151: 54-61. Go to original source... Go to PubMed...
    3. Zámečník L, Červený R, Hollý M, Krčma M. Erektilní dysfunkce: doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře 2018. Centrum doporučených postupů pro praktické lékaře. Společnost všeobecného lékařství, 2018.
    4. Zvěřina J. Erektilní dysfunkce a mezioborový pohled na jejich léčbu. Prakt. lékáren. 2013; 9(4-5): 161-164.
    5. Hatzimouratidis K, Giuliano F, Moncada I, et al. EAU Guidelines on Erectile Dysfunction, Premature Ejaculation, Penile Curvature and Priapism. European Association of Urology 2019. [cit. 2020-09-29]. Dostupné z: https://uroweb.org/wp‑content/uploads/EAU‑Guidelines‑on‑Male‑Sexual‑Dysfunction-2019.pdf
    6. Erektilní dysfunkce [online]. Česká urologická společnost ČLS JEP. [cit. 2020-09-29]. Dostupné z: https://www.cus.cz/pro‑pacienty/diagnozy/erektilni‑dysfunkce/.
    7. Shoshany O, Katz DJ, Love C. Much more than prescribing a pill - assessment and treatment of erectile dysfunction by the general practitioner. Aust Fam Physician 2017. 46(9): 634-639. Go to PubMed...
    8. Rosen RC, Riley A, Wagner G, et al. The International Index of Eectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49(6): 822-830. Go to original source... Go to PubMed...
    9. Goldstein I, Mulhall JP, Bushmakin AG, et al. The Erection Hardness Score and its relationship to successful sexual intercourse. J Sex Med. 2008; 5: 2374-2380. Go to original source... Go to PubMed...
    10. Šrámková T. Sexuologie pro zdravotníky. Praha: Galén, 2015. ISBN 978-80-7492-162-9.
    11. Jain P, Rademaker AW, McVary KT. Testosterone supplementation for erectile dysfunction: results of a meta‑analysis. J Urol. 2000; 164(2): 371-375. Go to original source... Go to PubMed...
    12. Corona G, Isidori AM, Buvat J, et al. Testosterone supplementation and sexual function: a meta‑analysis study. J Sex Med. 2014; 11(6): 1577-1592. Go to original source... Go to PubMed...
    13. Souhrn údajů o léčivém přípravku vybraných HVLP [online]. Státní ústav pro kontrolu léčiv - Databáze léků. [cit. 2020-10-01]. Dostupné z: https://www.sukl.cz/modules/medication/search.php.
    14. Madeira CR, Tonin FS, Fachi MM, et al. Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta‑analysis and multicriteria decision analysis [online]. World J Urol. 2020. [cit. 2020-09-18]. Dostupné z: https://link‑springer‑com.ezproxy.is.cuni.cz/article/10.1007/s00345-020-03233-9. Go to original source... Go to PubMed...
    15. Porst H, Hell‑Momeni K, Buttner H. Chronic PDE-5 in‑hibition in patients with erectile dysfunction: new treat‑ment approach using once daily tadalafi l. Urologe A 2009; 48(11): 1320-1329. Go to original source... Go to PubMed...
    16. Ismail EA, El‑Sakka AI. Innovative trends and perspectives for erectile dysfunction treatment: A systematic review. Arab J Urol. 2016;14(2): 84-93. Go to original source... Go to PubMed...
    17. Fink HA, MacDonald R, Rutks IR, Wilt TJ. Trazodone for erectile dysfunction: a systematic review and meta‑analysis. BJU Int. 2003. 92(4): 441-446. Go to original source... Go to PubMed...
    18. Rezaee ME, Gross MS. Are We Overstating the Risk of Priapism With Oral Phosphodiesterase Type 5 Inhibitors?. J Sex Med. 2020;17(8): 1579-1582. Go to original source... Go to PubMed...
    19. Šrámková T. Terapie erektilní dysfunkce dle Guidelines Evropské urologické asociace. Kardiol Rev Int Med 2014; 16(4): 288-293.
    20. Derouet H, Weirauch A, Bewermeier H. Prostaglandin E1 (PGE1) in diagnosis and long‑term therapy of erectile dysfunction. Urologe A. 1996; 35(1): 62-67. Go to PubMed...
    21. Lee S, Lee J, Choi YW. Design and evaluation of prostaglandin E1 (PGE1) intraurethral liquid formulation employing self‑microemulsifying drug delivery system (SMEDDS) for erectile dysfunction treatment. Biol Pharm Bull. 2008. 31(4): 668-672. Go to original source... Go to PubMed...
    22. Zámečník L. Novák J. Nový typ léčby poruch erekce na trhu v ČR - aplikace alprostadilu ve formě krému. Urol. praxi 2016; 17(5): 217-222. Go to original source...
    23. Ritchie R, Sullivan M. Endothelins & erectile dysfunction. Pharmacolog. Res. 2011; 63: 496-501. Go to original source... Go to PubMed...
    24. Khan MA, Calvert RC, Sullivan ME, et al. Normal and pathological erectile function: the potential clinical role of endothelin-1 antagonists. Curr Drug Targets. 2000; 1(3): 247-260. Go to original source... Go to PubMed...
    25. Borrelli F, Colalto C, Delfino DV, et al. Herbal Dietary Supplements for Erectile Dysfunction: A Systematic Review and Meta‑Analysis. Drugs. 2018, 78(6): 643-673. Go to original source... Go to PubMed...
    26. Shamloul R. Natural Aphrodisiacs. J. Sex. Med. 2010; 7: 39-49. Go to original source... Go to PubMed...
    27. Jackson G, Boon N, Eardely I, et al. Eectile dysfunction and coronory artery disease prediction: evidence - based Guyance and consensus. Int J Clin Pract. 2010; 64(7): 848-857. Go to original source... Go to PubMed...
    28. De Busc R, Drory R, Goldstein I, et al. Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of the Princeton Consensus panel. Am J Cardiol. 2000; 86: 175-181. Go to original source... Go to PubMed...
    29. Phé V, Roupret M. Erectile dysfunction and diabetes. A review of the current evidence‑based medicine and a synthesis of the main available therapies. Diabetes Metab. 2012; 38: 1-13. Go to original source... Go to PubMed...
    30. Morales AM, Hatzichristou D, Lladós JR, et al. Community Pharmacy Detection of Erectile Dysfunction in Men with Risk Factors or Who Seek Treatment or Advice but Lack a Valid Prescription. The Journal of Sexual Medicine. 2013, 10(9): 2303-2311. Go to original source... Go to PubMed...
    31. Taylor DG., Giuliano F, Hackett G, et al. The pharmacist's role in improving the treatment of erectile dysfunction and its underlying causes. Research in Social and Administrative Pharmacy. 2019; 15(5): 591-599 Go to original source... Go to PubMed...
    32. Oakley N, Moore KTH. Vacuum devices in erectile dysfunction: indications and efficacy. BJU International. 1998; 82(5): 673-681. Go to original source... Go to PubMed...
    33. Odborné poradenství v lékárnách. [online]. Česká lékárnická komora [cit. 2020-10-28]. Dostupné z: https://www.sukl.cz/modules/medication/search.php.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.